OPRX – optimizerx corporation (US:NASDAQ)

News

OptimizeRx Co. (NASDAQ: OPRX) had its price target raised by analysts at JMP Securities from $15.00 to $16.00. They now have a "market outperform" rating on the stock.
OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock.
OptimizeRx Reports First Quarter 2024 Financial Results [Yahoo! Finance]
OptimizeRx Reports First Quarter 2024 Financial Results
OptimizeRx to Participate in Upcoming Investor Conferences 
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com